Times Reporter of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.

Press releases published on October 16, 2026

Oct. 16, 2026

Tribuna.com Lança Versão em Português do Brasil com Estatísticas de Futebol e Exclusivas de Transferências

Indeterminate EIN Presswire

Oct. 16, 2026

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

Indeterminate GlobeNewswire

Oct. 16, 2026

San Lorenzo Announces Upsize of Private Placement to Up to $80 Million

Indeterminate GlobeNewswire

Oct. 16, 2026

Avicanna Transitions US Listing to OTCQB

Indeterminate GlobeNewswire

Oct. 16, 2026

Granting of Incentive Stock Options

Indeterminate GlobeNewswire

Oct. 16, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 16, 2026

Prelude Therapeutics to Participate in the Chardan Healthcare Conference

Indeterminate GlobeNewswire

Oct. 16, 2026

Technology Drives the Future of Travel: JETOUR Continues to Expand Its 'Travel+' Ecosystem

Indeterminate EIN Presswire

Oct. 16, 2026

Henan Mission Machinery Launches Integrated Destoner Suite for Complete Stone Removal and Dust Control

Indeterminate EIN Presswire

Oct. 16, 2026

Houston’s 2025 $42.9B Real Estate Market: Umar Ali of Owth & Mophet Construction

Indeterminate EIN Presswire

Oct. 16, 2026

Exiro Nickel Completes Acquisition of Thompson Operations, Launches New Chapter for Northern Manitoba Mining

Indeterminate GlobeNewswire

Oct. 16, 2026

NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone

Indeterminate GlobeNewswire

Oct. 16, 2026

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology

Indeterminate GlobeNewswire

Oct. 16, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 16, 2026

Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

Oct. 16, 2026

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Indeterminate GlobeNewswire

Oct. 16, 2026

San Lorenzo Announces Private Placement of Up to $40 Million

Indeterminate GlobeNewswire

Oct. 16, 2026

MEXC Releases October 2026 Proof of Reserves, Reinforcing User Trust Through Verifiable Transparency

Indeterminate GlobeNewswire

Oct. 16, 2026

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

Indeterminate GlobeNewswire

Oct. 16, 2026

Paladin Announces Availability of Notice of Meeting for Annual General Meeting

Indeterminate GlobeNewswire